Search

Your search keyword '"Martinez Picado, J"' showing total 482 results

Search Constraints

Start Over You searched for: Author "Martinez Picado, J" Remove constraint Author: "Martinez Picado, J"
482 results on '"Martinez Picado, J"'

Search Results

2. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

3. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

7. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

8. Fucosylated N-glycans as early biomarkers of COVID-19 severity

10. OP 1.9 – 00042 Measuring the impact of early 3BNC117 intervention at ART initiation on the productive reservoir in a cohort of diverse viral subtypes: results from the VIP-SPOT assay in the eCLEAR trial

12. ABX464 Decreases the Total Human Immunodeficiency Virus (HIV) Reservoir and HIV Transcription Initiation in CD4+ T Cells From Antiretroviral Therapy-Suppressed Individuals Living With HIV

14. Post COVID-19 Condition in Children and Adolescents: An Emerging Problem

15. Autopsy Study Defines Composition and Dynamics of the HIV-1 Reservoir after Allogeneic Hematopoietic Stem Cell Transplantation with CCR5 Delta 32/Delta 32 Donor Cells

16. Altered T-cell subset distribution in the viral reservoir in HIV-1-infected individuals with extremely low proviral DNA

17. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

21. Auto-antibodies against type I IFNs in patients with life-threatening COVID-19

23. Autoantibodies neutralizing type I IFNs are present in similar to 4\% of uninfected individuals over 70 years old and account for similar to 20\% of COVID-19 deaths

24. Dynamics of the Decay of Human Immunodeficiency Virus (HIV) RNA and Distribution of Bictegravir in the Genital Tract and Rectum in Antiretroviral-naive Adults Living With HIV-1 Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide (Spanish HIV/AIDS Research Network, PreEC/RIS 58)

25. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

26. Early Initiation of Antiretroviral Therapy Following In Utero HIV Infection Is Associated With Low Viral Reservoirs but Other Factors Determine Viral Rebound

29. Launching a multidisciplinary European collaboration towards a cure for HIV: The EU2Cure Consortium

30. Launching a multidisciplinary European collaboration towards a cure for HIV:The EU2Cure Consortium

34. HIV evolution: CTL escape mutation and reversion after transmission

35. 1275P Extended follow-up of DURVAST trial: A phase II study evaluating durvalumab treatment in HIV-1-infected patients with solid tumours by the Spanish lung cancer group

36. Transcriptomic analysis of pre-treatment tissue samples to predict clinical benefit to durvalumab in HIV-infected cancer patients

37. Evidence for HIV-1 cure after CCR5 Delta 32/Delta 32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report

38. Transcriptional signature of resting-memory CD4 T cells differentiates spontaneous from treatment-induced HIV control

39. Dasatinib protects humanized mice from acute HIV-1 infection

44. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

45. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

46. Auto-antibodies against type I IFNs in patients with life-threatening COVID-19

47. Recommendations for analytical antiretroviral treatment interruptions in HIV research trials: report of a consensus meeting

48. HIV-1 remission following CCR5 Delta 32/Delta 32 haematopoietic stem-cell transplantation

49. Plasma Epstein-Barr Virus Load as an Early Biomarker and Prognostic Factor of Human Immunodeficiency Virus-related Lymphomas

Catalog

Books, media, physical & digital resources